COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.
Market Analysis and Insights: Global COVID-19 Diagnostic Testing Market
The global COVID-19 Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global COVID-19 Diagnostic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global COVID-19 Diagnostic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global COVID-19 Diagnostic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global COVID-19 Diagnostic Testing market.
COVID-19 Diagnostic Testing Breakdown Data by Type
Nucleic Acid Testing
Antibody Testing
COVID-19 Diagnostic Testing Breakdown Data by Application
Hospitals
Scientific Research
Based on regional and country-level analysis, the COVID-19 Diagnostic Testing market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global COVID-19 Diagnostic Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Market Analysis and Insights: Global COVID-19 Diagnostic Testing Market
The global COVID-19 Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global COVID-19 Diagnostic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global COVID-19 Diagnostic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global COVID-19 Diagnostic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global COVID-19 Diagnostic Testing market.
COVID-19 Diagnostic Testing Breakdown Data by Type
Nucleic Acid Testing
Antibody Testing
COVID-19 Diagnostic Testing Breakdown Data by Application
Hospitals
Scientific Research
Based on regional and country-level analysis, the COVID-19 Diagnostic Testing market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global COVID-19 Diagnostic Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Nucleic Acid Testing
1.2.3 Antibody Testing
1.3 Market by Application
1.3.1 Global COVID-19 Diagnostic Testing Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global COVID-19 Diagnostic Testing Market Perspective (2015-2026)
2.2 Global COVID-19 Diagnostic Testing Growth Trends by Regions
2.2.1 COVID-19 Diagnostic Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 COVID-19 Diagnostic Testing Historic Market Share by Regions (2015-2020)
2.2.3 COVID-19 Diagnostic Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top COVID-19 Diagnostic Testing Players by Market Size
3.1.1 Global Top COVID-19 Diagnostic Testing Players by Revenue (2015-2020)
3.1.2 Global COVID-19 Diagnostic Testing Revenue Market Share by Players (2015-2020)
3.2 Global COVID-19 Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by COVID-19 Diagnostic Testing Revenue
3.4 Global COVID-19 Diagnostic Testing Market Concentration Ratio
3.4.1 Global COVID-19 Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Diagnostic Testing Revenue in 2019
3.5 Key Players COVID-19 Diagnostic Testing Area Served
3.6 Key Players COVID-19 Diagnostic Testing Product Solution and Service
3.7 Date of Enter into COVID-19 Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 Diagnostic Testing Breakdown Data by Type (2015-2026)
4.1 Global COVID-19 Diagnostic Testing Historic Market Size by Type (2015-2020)
4.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Type (2021-2026)
5 COVID-19 Diagnostic Testing Breakdown Data by Application (2015-2026)
5.1 Global COVID-19 Diagnostic Testing Historic Market Size by Application (2015-2020)
5.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America COVID-19 Diagnostic Testing Market Size (2015-2026)
6.2 North America COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
6.3 North America COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
6.4 North America COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe COVID-19 Diagnostic Testing Market Size (2015-2026)
7.2 Europe COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
7.3 Europe COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
7.4 Europe COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China COVID-19 Diagnostic Testing Market Size (2015-2026)
8.2 China COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
8.3 China COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
8.4 China COVID-19 Diagnostic Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan COVID-19 Diagnostic Testing Market Size (2015-2026)
9.2 Japan COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
9.3 Japan COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
9.4 Japan COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia COVID-19 Diagnostic Testing Market Size (2015-2026)
10.2 Southeast Asia COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
10.3 Southeast Asia COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
10.4 Southeast Asia COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 Cellex
11.1.1 Cellex Company Details
11.1.2 Cellex Business Overview
11.1.3 Cellex COVID-19 Diagnostic Testing Introduction
11.1.4 Cellex Revenue in COVID-19 Diagnostic Testing Business (2015-2020))
11.1.5 Cellex Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott COVID-19 Diagnostic Testing Introduction
11.2.4 Abbott Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.2.5 Abbott Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche COVID-19 Diagnostic Testing Introduction
11.3.4 Roche Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.3.5 Roche Recent Development
11.4 BioMedomics
11.4.1 BioMedomics Company Details
11.4.2 BioMedomics Business Overview
11.4.3 BioMedomics COVID-19 Diagnostic Testing Introduction
11.4.4 BioMedomics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.4.5 BioMedomics Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD COVID-19 Diagnostic Testing Introduction
11.5.4 BD Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.5.5 BD Recent Development
11.6 Henry Schein
11.6.1 Henry Schein Company Details
11.6.2 Henry Schein Business Overview
11.6.3 Henry Schein COVID-19 Diagnostic Testing Introduction
11.6.4 Henry Schein Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.6.5 Henry Schein Recent Development
11.7 Safecare Bio-Tech
11.7.1 Safecare Bio-Tech Company Details
11.7.2 Safecare Bio-Tech Business Overview
11.7.3 Safecare Bio-Tech COVID-19 Diagnostic Testing Introduction
11.7.4 Safecare Bio-Tech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.7.5 Safecare Bio-Tech Recent Development
11.8 Mayo Clinic Laboratories
11.8.1 Mayo Clinic Laboratories Company Details
11.8.2 Mayo Clinic Laboratories Business Overview
11.8.3 Mayo Clinic Laboratories COVID-19 Diagnostic Testing Introduction
11.8.4 Mayo Clinic Laboratories Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.8.5 Mayo Clinic Laboratories Recent Development
11.9 Chembio Diagnostics
11.9.1 Chembio Diagnostics Company Details
11.9.2 Chembio Diagnostics Business Overview
11.9.3 Chembio Diagnostics COVID-19 Diagnostic Testing Introduction
11.9.4 Chembio Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.9.5 Chembio Diagnostics Recent Development
11.10 Mount Sinai Laboratory
11.10.1 Mount Sinai Laboratory Company Details
11.10.2 Mount Sinai Laboratory Business Overview
11.10.3 Mount Sinai Laboratory COVID-19 Diagnostic Testing Introduction
11.10.4 Mount Sinai Laboratory Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.10.5 Mount Sinai Laboratory Recent Development
11.11 Ortho Clinical Diagnostics
10.11.1 Ortho Clinical Diagnostics Company Details
10.11.2 Ortho Clinical Diagnostics Business Overview
10.11.3 Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Introduction
10.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.11.5 Ortho Clinical Diagnostics Recent Development
11.12 Zhejiang Orient Gene Biotech
10.12.1 Zhejiang Orient Gene Biotech Company Details
10.12.2 Zhejiang Orient Gene Biotech Business Overview
10.12.3 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Introduction
10.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.12.5 Zhejiang Orient Gene Biotech Recent Development
11.13 Innovita Biological Technology
10.13.1 Innovita Biological Technology Company Details
10.13.2 Innovita Biological Technology Business Overview
10.13.3 Innovita Biological Technology COVID-19 Diagnostic Testing Introduction
10.13.4 Innovita Biological Technology Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.13.5 Innovita Biological Technology Recent Development
11.14 Guangzhou Wondfo Biotech
10.14.1 Guangzhou Wondfo Biotech Company Details
10.14.2 Guangzhou Wondfo Biotech Business Overview
10.14.3 Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Introduction
10.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.14.5 Guangzhou Wondfo Biotech Recent Development
11.15 Guangdong Hecin-Scientific
10.15.1 Guangdong Hecin-Scientific Company Details
10.15.2 Guangdong Hecin-Scientific Business Overview
10.15.3 Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Introduction
10.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.15.5 Guangdong Hecin-Scientific Recent Development
11.16 Dynamiker Biotechnology (Tianjin)
10.16.1 Dynamiker Biotechnology (Tianjin) Company Details
10.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
10.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Introduction
10.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
11.17 ADVAITE
10.17.1 ADVAITE Company Details
10.17.2 ADVAITE Business Overview
10.17.3 ADVAITE COVID-19 Diagnostic Testing Introduction
10.17.4 ADVAITE Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.17.5 ADVAITE Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Nucleic Acid Testing
1.2.3 Antibody Testing
1.3 Market by Application
1.3.1 Global COVID-19 Diagnostic Testing Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global COVID-19 Diagnostic Testing Market Perspective (2015-2026)
2.2 Global COVID-19 Diagnostic Testing Growth Trends by Regions
2.2.1 COVID-19 Diagnostic Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 COVID-19 Diagnostic Testing Historic Market Share by Regions (2015-2020)
2.2.3 COVID-19 Diagnostic Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top COVID-19 Diagnostic Testing Players by Market Size
3.1.1 Global Top COVID-19 Diagnostic Testing Players by Revenue (2015-2020)
3.1.2 Global COVID-19 Diagnostic Testing Revenue Market Share by Players (2015-2020)
3.2 Global COVID-19 Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by COVID-19 Diagnostic Testing Revenue
3.4 Global COVID-19 Diagnostic Testing Market Concentration Ratio
3.4.1 Global COVID-19 Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Diagnostic Testing Revenue in 2019
3.5 Key Players COVID-19 Diagnostic Testing Area Served
3.6 Key Players COVID-19 Diagnostic Testing Product Solution and Service
3.7 Date of Enter into COVID-19 Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 Diagnostic Testing Breakdown Data by Type (2015-2026)
4.1 Global COVID-19 Diagnostic Testing Historic Market Size by Type (2015-2020)
4.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Type (2021-2026)
5 COVID-19 Diagnostic Testing Breakdown Data by Application (2015-2026)
5.1 Global COVID-19 Diagnostic Testing Historic Market Size by Application (2015-2020)
5.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America COVID-19 Diagnostic Testing Market Size (2015-2026)
6.2 North America COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
6.3 North America COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
6.4 North America COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe COVID-19 Diagnostic Testing Market Size (2015-2026)
7.2 Europe COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
7.3 Europe COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
7.4 Europe COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China COVID-19 Diagnostic Testing Market Size (2015-2026)
8.2 China COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
8.3 China COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
8.4 China COVID-19 Diagnostic Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan COVID-19 Diagnostic Testing Market Size (2015-2026)
9.2 Japan COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
9.3 Japan COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
9.4 Japan COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia COVID-19 Diagnostic Testing Market Size (2015-2026)
10.2 Southeast Asia COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
10.3 Southeast Asia COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
10.4 Southeast Asia COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 Cellex
11.1.1 Cellex Company Details
11.1.2 Cellex Business Overview
11.1.3 Cellex COVID-19 Diagnostic Testing Introduction
11.1.4 Cellex Revenue in COVID-19 Diagnostic Testing Business (2015-2020))
11.1.5 Cellex Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott COVID-19 Diagnostic Testing Introduction
11.2.4 Abbott Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.2.5 Abbott Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche COVID-19 Diagnostic Testing Introduction
11.3.4 Roche Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.3.5 Roche Recent Development
11.4 BioMedomics
11.4.1 BioMedomics Company Details
11.4.2 BioMedomics Business Overview
11.4.3 BioMedomics COVID-19 Diagnostic Testing Introduction
11.4.4 BioMedomics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.4.5 BioMedomics Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD COVID-19 Diagnostic Testing Introduction
11.5.4 BD Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.5.5 BD Recent Development
11.6 Henry Schein
11.6.1 Henry Schein Company Details
11.6.2 Henry Schein Business Overview
11.6.3 Henry Schein COVID-19 Diagnostic Testing Introduction
11.6.4 Henry Schein Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.6.5 Henry Schein Recent Development
11.7 Safecare Bio-Tech
11.7.1 Safecare Bio-Tech Company Details
11.7.2 Safecare Bio-Tech Business Overview
11.7.3 Safecare Bio-Tech COVID-19 Diagnostic Testing Introduction
11.7.4 Safecare Bio-Tech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.7.5 Safecare Bio-Tech Recent Development
11.8 Mayo Clinic Laboratories
11.8.1 Mayo Clinic Laboratories Company Details
11.8.2 Mayo Clinic Laboratories Business Overview
11.8.3 Mayo Clinic Laboratories COVID-19 Diagnostic Testing Introduction
11.8.4 Mayo Clinic Laboratories Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.8.5 Mayo Clinic Laboratories Recent Development
11.9 Chembio Diagnostics
11.9.1 Chembio Diagnostics Company Details
11.9.2 Chembio Diagnostics Business Overview
11.9.3 Chembio Diagnostics COVID-19 Diagnostic Testing Introduction
11.9.4 Chembio Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.9.5 Chembio Diagnostics Recent Development
11.10 Mount Sinai Laboratory
11.10.1 Mount Sinai Laboratory Company Details
11.10.2 Mount Sinai Laboratory Business Overview
11.10.3 Mount Sinai Laboratory COVID-19 Diagnostic Testing Introduction
11.10.4 Mount Sinai Laboratory Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.10.5 Mount Sinai Laboratory Recent Development
11.11 Ortho Clinical Diagnostics
10.11.1 Ortho Clinical Diagnostics Company Details
10.11.2 Ortho Clinical Diagnostics Business Overview
10.11.3 Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Introduction
10.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.11.5 Ortho Clinical Diagnostics Recent Development
11.12 Zhejiang Orient Gene Biotech
10.12.1 Zhejiang Orient Gene Biotech Company Details
10.12.2 Zhejiang Orient Gene Biotech Business Overview
10.12.3 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Introduction
10.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.12.5 Zhejiang Orient Gene Biotech Recent Development
11.13 Innovita Biological Technology
10.13.1 Innovita Biological Technology Company Details
10.13.2 Innovita Biological Technology Business Overview
10.13.3 Innovita Biological Technology COVID-19 Diagnostic Testing Introduction
10.13.4 Innovita Biological Technology Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.13.5 Innovita Biological Technology Recent Development
11.14 Guangzhou Wondfo Biotech
10.14.1 Guangzhou Wondfo Biotech Company Details
10.14.2 Guangzhou Wondfo Biotech Business Overview
10.14.3 Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Introduction
10.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.14.5 Guangzhou Wondfo Biotech Recent Development
11.15 Guangdong Hecin-Scientific
10.15.1 Guangdong Hecin-Scientific Company Details
10.15.2 Guangdong Hecin-Scientific Business Overview
10.15.3 Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Introduction
10.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.15.5 Guangdong Hecin-Scientific Recent Development
11.16 Dynamiker Biotechnology (Tianjin)
10.16.1 Dynamiker Biotechnology (Tianjin) Company Details
10.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
10.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Introduction
10.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
11.17 ADVAITE
10.17.1 ADVAITE Company Details
10.17.2 ADVAITE Business Overview
10.17.3 ADVAITE COVID-19 Diagnostic Testing Introduction
10.17.4 ADVAITE Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.17.5 ADVAITE Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
